| Type | Description |
|---|---|
| Definition | C-C motif chemokine ligand 20 |
| Date | Results | Publications |
|---|---|---|
| 2021-03-27 14:45:00 | EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer. | 32732864 |
| 2021-03-27 14:42:00 | Systematic reassessment of chemokine-receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22. | 32480426 |
| 2021-03-20 13:28:00 | EGFR/Ras-induced CCL20 production modulates the tumour microenvironment. | 32601464 |
| 2021-03-06 13:26:00 | Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20-CCR6 pathway. | 33113266 |
| 2020-11-21 13:25:00 | CCL20 is a novel ligand for the scavenging atypical chemokine receptor 4. | 32533638 |
| Type | IDs |
|---|---|
| Synonymous | CKb4, Exodus, LARC, MIP-3-alpha, MIP-3a, MIP3A, SCYA20, ST38 |
| Gene |
UniProtKB-ID:
CCL20_HUMAN
UniprotKB:
P78556
UniParc:
UPI000002B47F,
UPI00000339BD
EMBL:
AC073065,
D86955,
U77035,
U64197,
BC020698
Ensembl:
ENSG00000115009
KO:
hsa:6364
|
| Nucleutide sequences |
EMBL-CDS:
BAA13191.1,
AAC50943.1,
AAX93214.1,
AAB61534.1,
AAH20698.1
Ensembl_TRS:
ENST00000409189,
ENST00000358813
|
| Protein sequencees |
Ensembl_PRO:
ENSP00000386273,
ENSP00000351671
RefSeq:
NP_004582.1,
NP_001123518.1
|
| Others |
UniRef100:
UniRef100_P78556
UniRef90:
UniRef90_P78556
UniRef50:
UniRef50_P78556
UniGene:
Hs.75498
CCDS:
CCDS46536.1,
CCDS2469.1
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员